Skip to main content

Advertisement

SpringerLink
Log in

Diagnosis and management of primary breast sarcoma

  • Review
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Primary sarcoma of the breast is an extremely rare and heterogeneous disease. The rarity of this tumour limits most studies to small retrospective case reviews and case reports and has made clinicopathological study difficult. This article reviews the current literature on the diagnosis and management of breast sarcoma. The optimal treatment of breast sarcoma involves a multidisciplinary team prior to the initiation of treatment. Patients with tumours less than 5 cm that are easily resectable should undergo complete resection to the extent required to provide negative surgical margins. Negative surgical margins are more important for local recurrence and overall survival than the extent of surgical resection. Thus, neoadjuvant chemotherapy should be considered in order to shrink the tumour and help obtain negative surgical margins. Whether chemotherapy is indicated is primarily determined by tumour size. There is evidence that tumours larger than 5 cm are associated with an elevated risk of systemic failure and a poor prognosis. After surgical resection, patients with chemosensitive tumours should undergo additional adjuvant chemotherapy to treat micrometastatic disease. Radiation therapy should be used to improve local control in cases in which the tumour is larger than 5 cm and in cases with positive surgical margins. We propose to treat the patients according to the clinical practice guidelines in use for soft tissue sarcomas and address them to a reference centre for sarcoma. The appropriate treatment of breast sarcoma requires a multidisciplinary team approach necessitating experienced sarcoma surgeons, pathologists, radiotherapists and medical oncologists. Treating rare tumours in the same place should permit us to standardise pathological data and to include patients into multicentric radiotherapy or chemotherapy protocols to improve overall survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Chelius M (1828) Teleangiektasie. Heidelberger Klin Ann 499:517

  2. Müller J (1838) Über den feineren Bau und die Formen der krankhaften Geschwülste

  3. Lee B, Pack G (1931) Giant intracanalicular myxoma: the so-called cystosarcoma phyllodes mammae of Johannes Muller. Am J Cancer 93:250–268

    CAS  Google Scholar 

  4. Schmidt GB (1887) Ueber das angiosarkom der mamma. Arch Klin Chir 36:421–427

    Google Scholar 

  5. Simon W (1912) Myeloische Chloro-Leukämie (Chlorom) unter dem Bilde eines malignen Mammatumors. Berl Klin Wochenschr 49:893–897

    Google Scholar 

  6. Pollard MSG et al (1990) Breast sarcoma. A clinicopathologic review of 25 cases. Cancer 66(5):941–944

    Article  CAS  PubMed  Google Scholar 

  7. Terrier PH et al (1989) Primary breast sarcoma: a review of 33 cases with immunohistochemistry and prognostic factors. Breast Cancer Res Treat 13(1):39–48

    Article  CAS  PubMed  Google Scholar 

  8. McGowan TS et al (2000) An analysis of 78 breast sarcoma patients without distant metastases at presentation. Int J Radiat Oncol Biol Phys 46(2):383–390

    Article  CAS  PubMed  Google Scholar 

  9. May DS, Stroup NE (1991) The incidence of sarcomas of the breast among women in the United States, 1973–1986. Plast Reconstr Surg 87(1):193–194

    CAS  PubMed  Google Scholar 

  10. Fields RC et al (2008) Treatment and outcomes of patients with primary breast sarcoma. Am J Surg 196(4):559–561

    Article  PubMed  Google Scholar 

  11. Adem C et al (2004) Primary breast sarcoma: clinicopathologic series from the Mayo Clinic and review of the literature. Br J Cancer 91(2):237–241

    CAS  PubMed  Google Scholar 

  12. Bousquet G et al (2007) Outcome and prognostic factors in breast sarcoma: a multicenter study from the rare cancer network. Radiother Oncol 85:355–361

    Article  PubMed  Google Scholar 

  13. Lattes R (1978) Sarcomas of the breast. Int J Radiat Oncol Biol Phys 4(7–8):705–708

    CAS  PubMed  Google Scholar 

  14. McGregor GI, Knowling MA, Este FA (1994) Sarcoma and cystosarcoma phyllodes tumors of the breast: a retrospective review of 58 cases. Am J Surg 167(5):477–480

    Article  CAS  PubMed  Google Scholar 

  15. Confavreux C et al (2006) Sarcomas and malignant phyllodes tumours of the breast—a retrospective study. Eur J Cancer 42(16):2715–2721

    Article  CAS  PubMed  Google Scholar 

  16. Turner NC, Jones AL (2008) Management of breast cancer—Part I. BMJ 337:107–110

    Article  Google Scholar 

  17. Lum YW, Jacobs L (2008) Primary breast sarcoma. Surg Clin N Am 88:559–570

    Article  PubMed  Google Scholar 

  18. Karlsson P et al (1998) Soft tissue sarcoma after treatment for breast cancer—a Swedish population-based study. Eur J Cancer 34(13):2068–2075

    Article  CAS  PubMed  Google Scholar 

  19. Huang J, Mackillop WJ (2001) Increased risk of soft tissue sarcoma after radiotherapy in women with breast carcinoma. Cancer 92(1):172–180

    Article  CAS  PubMed  Google Scholar 

  20. Taghian A et al (1991) Long-term risk of sarcoma following radiation treatment for breast cancer. Int J Radiat Oncol Biol Phys 21(2):361–367

    CAS  PubMed  Google Scholar 

  21. Blanchard DK et al (2002) Radiation-induced breast sarcoma. Am J Surg 184(4):356–358

    Article  PubMed  Google Scholar 

  22. Blanchard DK et al (2003) Primary nonphylloides breast sarcomas. Am J Surg 186(4):359–361

    Article  PubMed  Google Scholar 

  23. Brady MS et al (1994) Post-treatment sarcoma in breast cancer patients. Ann Surg Oncol 1(1):66–72

    Article  CAS  PubMed  Google Scholar 

  24. Stewart FW, Treves N (1948) Lymphangiosarcoma in postmastectomy lymphedema: report of six cases in elephantiasis chirurgica. Cancer 1:64–81

    Article  CAS  PubMed  Google Scholar 

  25. McDivitt RW, Urban JA, Farrow JH (1967) Cystosarcoma phyllodes. Johns Hopkins Med J 120(1):33–45

    CAS  PubMed  Google Scholar 

  26. Malkin D et al (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250(4985):1233–1238

    Article  CAS  PubMed  Google Scholar 

  27. Hollstein M et al (1994) p53 mutations at A:T base pairs in angiosarcomas of vinyl chloride-exposed factory workers. Carcinogenesis 15(1):1–3

    Article  CAS  PubMed  Google Scholar 

  28. Barrow BJ et al (1999) Role of radiotherapy in sarcoma of the breast—a retrospective review of the MD Anderson experience. Radiother Oncol 52(2):173–178

    Article  CAS  PubMed  Google Scholar 

  29. Berg JW (1961) Stromal sarcomas of the breast. A unified approach to connective tissue sarcomas other than cystosarcoma phyllodes. Cancer 15(2):418–424

    Article  Google Scholar 

  30. Callery CD, Rosen PP, Kinne DW (1985) Sarcoma of the breast. A study of 32 patients with reappraisal of classification and therapy. Ann Surg 201(4):527–532

    Article  CAS  PubMed  Google Scholar 

  31. Christensen L et al (1988) Sarcomas of the breast: a clinico-pathological study of 67 patients with long term follow-up. Eur J Surg Oncol 14(3):241–247

    CAS  PubMed  Google Scholar 

  32. Gutman H et al (1994) Sarcoma of the breast: implications for extent of therapy. The MD Anderson experience. Surgery 116(3):505–509

    CAS  PubMed  Google Scholar 

  33. North JH et al (1998) Sarcoma of the breast: implications of the extent of local therapy. Am Surg 64(11):1059–1061

    PubMed  Google Scholar 

  34. Pandey M et al (2004) Primary sarcoma of the breast. J Surg Oncol 87(3):121–125

    Article  PubMed  Google Scholar 

  35. Zelek L et al (2003) Prognostic factors in primary breast sarcomas: a series of patients with long-term follow-up. J Clin Oncol 21(13):2583–2588

    Article  CAS  PubMed  Google Scholar 

  36. McDivitt RW, Stewart FW, Berg JW (1968) Atlas of tumor pathology. Tumors of the breast. Armed Forces Institute of Pathology, Washington, DC

    Google Scholar 

  37. Shabahang M et al (2002) Surgical management of primary breast sarcoma. Am Surg 68(8):673–677

    PubMed  Google Scholar 

  38. Ward RM, Evans HL (2006) Cystosarcoma phyllodes. A clinicopathologic study of 26 cases. Cancer 58(10):2282–2289

    Article  Google Scholar 

  39. Pencavel TD, Hayes A (2009) Breast sarcoma—a review of diagnosis and management. Int J Surg 7(1):20–23

    Article  PubMed  Google Scholar 

  40. Foxcroft LM, Evans EB, Porter AJ (2007) Difficulties in the pre-operative diagnosis of phyllodes tumours of the breast: a study of 84 cases. Breast 16(1):27–37

    Article  CAS  PubMed  Google Scholar 

  41. Elson BC et al (1992) Fibrosarcoma of the breast: mammographic findings in five cases. Am J Roentgenol 158(5):993–995

    CAS  Google Scholar 

  42. Liberman L et al (1996) Benign and malignant phyllodes tumors: mammographic and sonographic findings. Radiology 198(1):121–124

    CAS  PubMed  Google Scholar 

  43. Yang WT et al (2007) Mammary angiosarcomas: imaging findings in 24 patients. Radiology 242(3):725–734

    Article  PubMed  Google Scholar 

  44. Trent JC, Benjamin RS, Valero V (2001) Primary soft tissue sarcoma of the breast. Curr Treat Options Oncol 2(2):169–176

    Article  Google Scholar 

  45. Tan PH (2005) Breast phyllodes tumours—morphology and beyond. Galloway Mem Lect 34(11):671–677

    CAS  Google Scholar 

  46. Esposito NN et al (2006) Phyllodes tumor: a clinicopathologic and immunohistochemical study of 30 cases. Arch Pathol Lab Med 130(10):1516–1520

    PubMed  Google Scholar 

  47. Greene FL, Fritz AG, Balch CM (2002) AJCC cancer staging manual. Soft tissue sarcoma. Springer-Verlag, New York

    Google Scholar 

  48. Daigeler A et al (2009) Lymph node metastases in soft tissue sarcomas—a single center analysis of 1,597 patients. Langenbecks Arch Surg 394(2):321–329

    Article  CAS  PubMed  Google Scholar 

  49. Bakheet SM et al (1998) F-18 FDG whole-body positron emission tomography scan in primary breast sarcoma. Clin Nucl Med 23(9):604–608

    Article  CAS  PubMed  Google Scholar 

  50. Smola MG et al (1993) The impact of resection margins in the treatment of primary sarcomas of the breast. A clinicopathological study of 8 cases with review of literature. Eur J Surg Oncol 19(1):61–69

    CAS  PubMed  Google Scholar 

  51. Johnstone PAS et al (1993) Primary soft tissue sarcomas of the breast: local-regional control with post-operative radiotherapy. Int J Radiat Oncol Biol Phys 27(3):671–675

    CAS  PubMed  Google Scholar 

  52. Moore MP, Kinne DW (1996) Breast sarcoma. Surg Clin N Am 76(2):383–392

    Article  CAS  PubMed  Google Scholar 

  53. Monroe AT, Feigenberg SJ, Mendenhall NP (2003) Angiosarcoma after breast-conserving therapy. Cancer 97(8):1832–1840

    Article  PubMed  Google Scholar 

  54. Patel SR et al (1998) Results of two consecutive trials of dose-intensive chemotherapy with doxorubicin and ifosfamide in patients with sarcomas. Am J Clin Oncol 21(3):317–321

    Article  CAS  PubMed  Google Scholar 

  55. Patel SR et al (1997) High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies—dose-response and schedule dependence. J Clin Oncol 15(6):2378–2384

    CAS  PubMed  Google Scholar 

  56. Brennan M, Casper E, Harrison L (2008) Soft tissue sarcoma. In: DeVita JV, Hellman S, Rosenberg S (eds) Cancer: principles and practice of oncology. Lippincott Williams and Wilkins, Philadelphia, pp 1731–1852

    Google Scholar 

  57. Thalhammer M et al (2006) Hyperthermia as a therapeutic option in recurrent breast sarcoma. Eur J Surg Oncol 32(S1):64

    Article  Google Scholar 

  58. Issels RD et al (1990) Ifosfamide plus etoposide combined with regional hyperthermia in patients with locally advanced sarcomas: a phase II study. J Clin Oncol 8(11):1818–1829

    CAS  PubMed  Google Scholar 

  59. Issels RD (2008) Regional hyperthermia in high-risk soft tissue sarcomas. Curr Opin Oncol 20(4):438–443

    Article  PubMed  Google Scholar 

  60. Issels RD et al (2010) Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol. doi:10.1016/S1470-2045(10)70071-1

    PubMed  Google Scholar 

  61. Ciatto S et al (1992) Sarcomas of the breast: a multicenter series of 70 cases. Neoplasma 39(6):375–379

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Operative Reference Centre for Soft Tissue Sarcoma, BG University Hospital Bergmannsheil, Ruhr University Bochum, Bürkle-de-la Camp-Platz 1, 44789, Bochum, Nordrhein-Westfalen, Germany

    Sammy Al-Benna, Kerstin Poggemann, Hans-Ulrich Steinau & Lars Steinstraesser

Authors
  1. Sammy Al-Benna
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kerstin Poggemann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hans-Ulrich Steinau
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lars Steinstraesser
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sammy Al-Benna.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Al-Benna, S., Poggemann, K., Steinau, HU. et al. Diagnosis and management of primary breast sarcoma. Breast Cancer Res Treat 122, 619–626 (2010). https://doi.org/10.1007/s10549-010-0915-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-010-0915-y

Keywords

Search

Navigation